AU2001264789A1 - Protein powder for pulmonary delivery - Google Patents

Protein powder for pulmonary delivery

Info

Publication number
AU2001264789A1
AU2001264789A1 AU2001264789A AU6478901A AU2001264789A1 AU 2001264789 A1 AU2001264789 A1 AU 2001264789A1 AU 2001264789 A AU2001264789 A AU 2001264789A AU 6478901 A AU6478901 A AU 6478901A AU 2001264789 A1 AU2001264789 A1 AU 2001264789A1
Authority
AU
Australia
Prior art keywords
protein powder
pulmonary delivery
pulmonary
delivery
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264789A
Other languages
English (en)
Inventor
Meenakshi Ganapati Bhat
George William Cuff
Ronald Keith Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001264789A1 publication Critical patent/AU2001264789A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001264789A 2000-06-08 2001-05-31 Protein powder for pulmonary delivery Abandoned AU2001264789A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21042300P 2000-06-08 2000-06-08
US60210423 2000-06-08
PCT/US2001/016472 WO2001093837A2 (fr) 2000-06-08 2001-05-31 Poudre proteinique administree par voie pulmonaire

Publications (1)

Publication Number Publication Date
AU2001264789A1 true AU2001264789A1 (en) 2001-12-17

Family

ID=22782843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264789A Abandoned AU2001264789A1 (en) 2000-06-08 2001-05-31 Protein powder for pulmonary delivery

Country Status (2)

Country Link
AU (1) AU2001264789A1 (fr)
WO (1) WO2001093837A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797902A3 (fr) * 2000-12-29 2007-10-03 Advanced Inhalation Research, Inc. Particules à libération prolongée destinées à être inhalées
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
JP4792457B2 (ja) * 2004-03-26 2011-10-12 ユニヴァーシタ’デグリ ステュディ ディ パルマ 高度に呼吸に適したインスリンのマイクロ粒子
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
WO2008130220A1 (fr) * 2007-04-20 2008-10-30 N.V. Nutricia Procédé de dispersion d'acides aminés
WO2009020434A1 (fr) * 2007-08-07 2009-02-12 Nanomaterials Technology Pte Ltd Procédé de fabrication de particules de protéine microdimensionnée
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
KR101972301B1 (ko) 2009-11-13 2019-04-25 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ－１ 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물
BR112012011403B8 (pt) 2009-11-13 2021-05-25 Sanofi Aventis Deutschland composição farmacêutica líquida compreendendo um agonista glp-1 e metionina e uso da mesma
CA2809321C (fr) 2010-08-30 2018-08-14 Sanofi-Aventis Deutschland Gmbh Utilisation de lixisenatide pour fabrication de medicament pour traitement du diabete sucre de type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN103596584B (zh) 2011-06-15 2016-12-14 诺沃—诺迪斯克有限公司 多取代的胰岛素
HUE027989T2 (en) 2011-08-29 2016-11-28 Sanofi Aventis Deutschland A pharmaceutical composition for use in glycemic control in patients with type 2 diabetes
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
ES2841933T3 (es) 2014-10-31 2021-07-12 Univ Monash Formulación en polvo
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2018116300A1 (fr) * 2016-12-22 2018-06-28 Kamada Ltd. Formulations de poudre sèche d'alpha-1 antitrypsine
CN113194929B (zh) 2018-12-21 2022-12-09 诺和诺德股份有限公司 Glp-1肽的喷雾干燥工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
NZ292980A (en) * 1994-09-29 1999-02-25 Andaris Ltd Smooth, spherical water-soluble microparticles as therapeutic or diagnostic vehicles
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
CA2341454A1 (fr) * 1998-08-28 2000-03-09 Benjamin Lee Hughes Procede pour administrer des peptides insulinotropiques
BR0004152A (pt) * 1999-01-18 2000-11-21 Lg Chemichal Ltd Micropartìculas lipófilas contendo um medicamento protéico ou antìgeno e preparado compreendendo o mesmo

Also Published As

Publication number Publication date
WO2001093837A3 (fr) 2002-05-02
WO2001093837A2 (fr) 2001-12-13

Similar Documents

Publication Publication Date Title
AU2001264789A1 (en) Protein powder for pulmonary delivery
AU2001232799A1 (en) Protein c derivatives
AU2001233201A1 (en) Dry powder inhaler
AU1409801A (en) Powder inhaler
AU2002223028A1 (en) Inhaler
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU2001232017A1 (en) Pharmaceutical composition for pulmonary delivery
AU3201701A (en) Pharmaceutical composition for pulmonary delivery
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2002239291A1 (en) G protein coupled receptors
AU2001259450A1 (en) Cytoskeleton-associated proteins
AU2001296389A1 (en) Stable peptide formulations
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2001241044A1 (en) Mitf-associated proteins
AU2001278777A1 (en) Irap-binding protein
AU6444600A (en) New protein
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001232068A1 (en) Delivery capsules
AU7682600A (en) Sildenafil preparation
AU2001263445A1 (en) Methods for protein design
AU2001294911A1 (en) Carbohydrate-associated proteins
AU2001277614A1 (en) Novel proteins
AU2002357873A1 (en) Carbohydrate-associated proteins